China
Fund focus: Yunqi reaffirms its enterprise focus
Yunqi Partners was the first Chinese GP dedicated to enterprise services and now claims to be the largest early-stage investor in the space. SaaS, in various forms, will account for the bulk of Fund III
China's Yunqi closes third US dollar fund at $300m
Yunqi Partners, an early-stage investment firm focused on enterprise software and services in China, has raised $300 million for its third US dollar-denominated fund.
China's Source Code raises $1.1b renminbi fund
Chinese venture capital firm Source Code Capital has raised RMB7 billion ($1.1 billion) for its fifth renminbi-denominated fund after approximately three months in the market.
China in six trends
Key themes in China private equity fundraising, investment, and exits
PE-backed MicroTech Medical targets $254m Hong Kong IPO
MicroTech Medical, a China-based manufacturer of insulin pumps for diabetes sufferers that counts Lilly Asia Ventures (LAV) and Qiming Venture Partners among its investors, is looking to raise up to HK$1.98 billion ($254 million) in a Hong Kong IPO.
China biotech start-up LianBio files for US IPO
LianBio, a two-year-old Chinese biotech start-up incubated by life sciences investor Perceptive Advisors, has filed for a US IPO.
China Renaissance hits first close on flagship US dollar fund
Huaxing Growth Capital, a new economy-focused private equity division of China Renaissance, has reached the first close on its fourth US dollar-denominated fund of $550 million.
Chinese EV maker WM Motor raises $300m
Chinese electric vehicle (EV) manufacturer WM Motor has raised $300 million in the extended Series D round led by Hong Kong telecommunication company PCCW and shipping company Shun Tak Holdings.
China biotech: Going global
A gradual shift in focus from sourcing assets from overseas for application in China to bringing China-made treatments to the world is challenging the notion of what constitutes a local biotech start-up
China SaaS: Path to profitability
COVID-19 has driven enterprise uptake of software-as-a-service solutions in China, but paying customers are still relatively few. Other markets offer some pointers on monetization
Q&A: Poema Global's Homer Sun
Morgan Stanley Private Equity Asia’s former CIO explains why he likes special purpose acquisition companies (SPACs) and what drew him to electric scooter and mobility technology player Gogoro
Tiger Global leads $50m round for China's DataCloak
China-based cyber security start-up DataCloak has raised $50 million in an extended Series B round led by Tiger Global Management. Existing investors Matrix Partners China, Jeneration Capital, GL Ventures and GSR Ventures re-upped.
China autonomous sanitation vehicle maker raises $250m
CowaRobot, a Chinese autonomous driving technology developer with an initial focus on sanitation vehicles, has raised $250 million in Series C funding.
China robotics player Mech-Mind raises $154m
Chinese industrial robotics supplier Mech-Mind has raised nearly RMB1 billion ($154 million) in a Series C funding round led by Meituan and IDG Capital.
Deal focus: Investors flock to SaaS specialist Ones
China’s Ones aspires to become Atlassian rather than Slack, catering to software developers working on complicated projects. Effective localization is partly responsible for a surge in VC investment
Evergrande EV unit cancels listing, suffers cash crunch
Evergrande New Energy Vehicle (NEV) Group, the Hong Kong-listed electric vehicle unit of troubled Chinese real estate developer Evergrande has canceled a planned secondary listing on Shanghai's Star Market and warned investors of a cash shortage.
PAG backs China AI investment management start-up
PAG has led a $100 million round for DataYes, a China-based provider of artificial intelligence-enabled investment management solutions for the financial services industry.
GM invests $300m in China autonomous driving player Momenta
General Motors (GM) has entered China’s autonomous driving industry with a $300 million investment in Momenta, a local developer of sensor technology.
China's Broncus raises $215m in IPO, struggles on HK debut
Broncus Holding Corporation, a China-based manufacturer of medical devices used to treat lung diseases, plunged 12.8% on its Hong Kong trading debut following a HK$1.67 billion ($215 million) IPO.
China autonomous driving chip start-up hits $2b valuation
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has raised several hundred million dollars through two funding rounds at a valuation of $2 billion.
China AR glasses maker Nreal gets $100m Series C
Nreal, a Chinese manufacturer of advanced artificial reality (AR) glasses that resemble normal sunglasses, has raised a Series C of $100 million led by Nio Capital, Yunfeng Capital, and Hongtai Capital.
